Global Plaque Modification Devices
At cognitive, a dedicated team has worked on this report, we have disclosed one of the team member involved in the publication and client consultation process for your reference. You can initiate the discussion her via Book an appointment
At cognitive, our research analyst works closely with Plaque Modification Devices market experts to validate the gathered data and have the expert's opinion available for our clients. You can book a consultation call with our research analyst and industry experts on board (Subject to time availability and paid consultation services)
The base year for the analysis is 2025. Historical data has been considered for the period from 2022 to 2025. The year 2026 is considered as the estimated base for forecasting, with projections covering the period from 2026 to 2034. When we deliver the report that time we updated report data till the purchase date.
From the database of Cognitive, this is an unique identification number of reports and it will also have different reports associated with it.
Report edition's total number of pages for pdf format (Approximate)
Rating and review received by the reader or subscriber of the said report.
Athenaeum Visualization Dashboard: Access your purchased data/Report/Service through a sophisticated, interactive interface. The Athenaeum Dashboard allows you to preview data/reports and store them in a customizable dashboard, enabling you to filter metrics and uncover deeper trends specific to your enterprise needs.
PDF Access: To ensure the highest level of data integrity and confidentiality, your premium report editions are delivered as password-protected PDF files. These are securely shared via email and remain accessible within your dedicated Athenaeum account for future reference.
Versatile Multi-Format Export (Excel & MS Word): We provide the flexibility to integrate our research directly into your internal workflows. Upon request, relevant quantitative data and qualitative insights from your purchased reports can be provided in fully editable Microsoft Excel and Word formats.
Multiple Cloud Accounts: Benefit from a dedicated, encrypted cloud account that ensures your market intelligence is available on-demand. Access your research from any device, at any time, and from any location. Multiple Accounts facilitating seamless collaboration across your collegue or whole organization.
Athenaeum AI Assistant(Value-Added Service): Elevate your research capabilities with Athenaeum AI Assistant, our proprietary 24/7 research assistant. Equivalent in depth to a dedicated research analyst, this AI-driven tool provides round-the-clock data support and instant insights to help you navigate complex market landscapes in real-time.
As Cognitive a market research and consulting firm, we can provide Plaque Modification Devices market Analysis and consultation services with the help of our data collection processes and Proprietary research methodology called Full Truth. We have in-house team of research analysts and network of industry experts on board. In fact, we provided high-impact consualtion services to the listed client in competitior analysis. As an extension of our bespoke consulting engagements, we also provide access to Proprietary datasets of market analysis publish, making authoritative industry intelligence accessible to the public domain.
Proprietary Database, Market Surveys, Strategic Consultation & Advisory Services, Industry & Competitive Intelligence. along with Report Access and Athenaeum Dashboard Subscription — Revenue, Volume, Production, Trade Analysis, value chain and supply chain analysis, Market Size, Share, Forecast, Drivers, Trends, Growth Opportunities, ESG and more.
| Data Timeline | Historical Data: 2022-2025 | Base Year: 2025 | Forecast Period: 2026-2034 |
|---|---|
| Product Type Outlook: Segment Analysis | Atherectomy Devices, Thrombectomy Devices, Chronic Total Occlusion (CTO) Devices, Embolic Protection Devices (EPD) |
| Application Outlook: Segment Analysis | Coronary Artery Disease, Peripheral Artery Disease, Neurovascular Disease, Others |
| End-user Outlook: Segment Analysis | Hospitals, Specialty Clinics, Ambulatory Surgical Centers |
|---|---|
| Regions & Countries Analysis |
|
Share your contact details to receive free updated sample copy/pages of the recently published edition of Plaque Modification Devices Market Report 2025.
According to Cognitive Market Research, the global Plaque Modification Devices Market size will be USD 2142.5 million in 2025. It will expand at a compound annual growth rate (CAGR) of 8.80% from 2025 to 2033.
Market Drivers:
|
Market Restrains:
|
Market Trends:
|
| Market Size | 2021 (A) | 2025 (A) | 2033 (P) | CAGR |
|---|---|---|---|---|
| Global Market Size | xxxx | xxxx | xxxx | xxxx |
| Country Market Size | xxxx | xxxx | xxxx | xxxx |
| North Americ Market Size | xxxx | xxxx | xxxx | xxxx |
| Europe Market Size | xxxx | xxxx | xxxx | xxxx |
| Asia Pacific Market Size | xxxx | xxxx | xxxx | xxxx |
| South America Market Size | xxxx | xxxx | xxxx | xxxx |
| Middle East Market Size | xxxx | xxxx | xxxx | xxxx |
| Africa Market Size | xxxx | xxxx | xxxx | xxxx |
Plaque Modification Devices Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Plaque Modification Devices Market is observing vast growth owing to the increasing prevalence of cardiovascular diseases (CVD) and evolving technologies for minimally invasive procedures. Arterial plaque accumulation or atherosclerosis is one of the main causes of heart attack and stroke; there is a stringent need for good medical procedures. Plaque modification equipment, including atherectomy devices, laser systems, and balloons, is intended to ablate or alter arterial plaque, enhancing blood flow and minimizing the likelihood of major cardiovascular events. Government programs and healthcare policies promoting cardiovascular wellness are further driving market growth. Organizations such as the World Health Organization (WHO) and the National Institutes of Health (NIH) emphasize the need for early diagnosis and proper treatment to control CVDs. Moreover, advances in technology, such as AI-based imaging devices and bioresorbable stents, are transforming plaque modification procedures, rendering treatments safer and more effective. Nevertheless, factors such as the high cost of devices, regulatory requirements, and reliance on imports could slow down market growth, particularly in developing countries.
In March 2024, Boston Scientific received U.S. FDA approval for the AGENT™ Drug-Coated Balloon, designed to treat coronary in-stent restenosis. This innovation offers a safe and effective alternative to traditional therapies, aiming to reduce the recurrence of arterial plaque buildup. https://news.bostonscientific.com/2024-03-01-Boston-Scientific-Receives-FDA-Approval-for-the-AGENT-TM-Drug-Coated-Balloon#:~:text=MARLBOROUGH%2C%20Mass.%2C%20March%201,patients%20with%20coronary%20artery%20disease.
Cardiovascular diseases (CVDs) are the main cause of death worldwide, causing an estimated 17.9 million deaths per year. These diseases include a variety of heart and blood vessel disorders, such as coronary heart disease, cerebrovascular disease, and rheumatic heart disease. Remarkably, more than 75% of CVD deaths take place in low- and middle-income nations, highlighting a key global health inequality. In India, the condition is especially alarming; in 2016, 63% of all deaths were due to non-communicable diseases (NCDs), 27% of which were specifically due to CVDs. Additionally, CVDs contributed to 45% of deaths among people aged 40-69 years in India. This rising prevalence is primarily fueled by behavioral risk factors like unhealthy eating habits, physical inactivity, smoking, and excessive alcohol intake, resulting in diseases like hypertension, diabetes, and obesity. The rising burden of CVDs requires more medical interventions, such as the creation and use of plaque modification devices, to control and reduce the effects of these diseases.
https://www.who.int/health-topics/cardiovascular-diseases#tab=tab_1
The world population is undergoing a radical demographic change, with the population above 60 years expected to double from 12% in 2015 to 22% by 2050. The rise translates into about 2.1 billion older persons around the world in 2050. Interestingly, 80% of these aged persons will live in low- and middle-income nations. This growing population of geriatric individuals is coupled with an increased rate of chronic health conditions, among them cardiovascular diseases, that rank among the most common causes of morbidity and mortality across the world. The rising incidence of such ailments demands sophisticated medical care, hence increasing the need for plaque modification devices and other similar healthcare interventions.
India's health device industry is highly dependent on imports, and about 80% of its needs are imported from nations such as the United States, Germany, China, Singapore, and the Netherlands. This makes it expensive to procure advanced health devices, such as plaque modification devices, because of import taxes and duties. The high price of such imports is a major hindrance to their use by many in resource-poor environments. To solve this problem, the Indian government has launched programs like the Production Linked Incentive (PLI) Scheme and the Promotion of Medical Device Parks with the objective of increasing domestic production and decreasing import dependence. However, until these programs bring significant results, the excessive reliance on imports continues to be a limitation on the affordability and availability of advanced medical devices in India.
The convergence of artificial intelligence (AI) and robotics is revolutionizing plaque management in healthcare. Researchers have developed AI algorithms capable of analyzing coronary computed tomography angiography (CTA) images to measure plaque buildup rapidly and accurately, predicting heart attack risks within five years. These AI tools can quantify plaque from CTA images in just five to six seconds, a process that traditionally takes experts 25 to 30 minutes. ? In dentistry, AI-powered smart toothbrushes have been developed to improve oral hygiene by reminding patients to brush, interpreting brushing efficiency, and indicating areas that require more attention. These advancements aim to enhance plaque control and overall oral health. ? Additionally, robotic systems are being designed to automate daily brushing and flossing tasks. For instance, a proof-of-concept robotic system utilizes iron oxide nanoparticles with catalytic and magnetic properties to form structures that effectively remove plaque or act as floss-like cleaners. This innovation represents a significant leap toward precise plaque management and disease prevention.
The market for plaque modification devices is highly growing due to constant advances in medical technologies. Advances like drug-eluting balloons, bioresorbable stents, and laser atherectomy systems have been introduced, featuring better patient care and fueling the market growth. The technologies enhance the effectiveness of plaque removal procedures, shorten recovery times, and lower complications related to conventional procedures. The increasing need for minimally invasive treatments further drives the uptake of these cutting-edge devices, with the benefits of shorter recovery times and lower hospital stays. Artificial intelligence and machine learning integration in plaque modification procedures enable more accurate and individualized treatment planning, facilitating decision-making and better patient outcomes. These technologies are set to transform the plaque modification devices market, offering more efficient treatment options for cardiovascular disease patients.?
We have various report editions of Plaque Modification Devices Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
The Plaque Modification Devices Market is highly competitive, characterized by the presence of several global and regional players offering a wide range of products. Key companies in the market, such as Boston Scientific Corporation, B. Braun Melsungen, BD (Becton Dickinson and Company), Cardinal Health, Medtronic, and others, dominate through their extensive product portfolios, strong distribution networks, and focus on innovation.
In June 2024, Boston Scientific announced a definitive agreement to acquire Silk Road Medical, Inc., a company specializing in minimally invasive products for stroke prevention in patients with carotid artery disease. This strategic move aims to enhance Boston Scientific's vascular portfolio and address plaque-related conditions. https://news.bostonscientific.com/2024-06-18-Boston-Scientific-Announces-Agreement-to-Acquire-Silk-Road-Medical,-Inc In March 2021, Medtronic will offer the HawkOne™ Directional Atherectomy System, designed to treat peripheral arterial disease by removing plaque in both above-the-knee interventions. This system addresses various plaque morphologies, including severe calcium deposits. https://www.medtronic.com/en-us/healthcare-professionals/products/cardiovascular/directional-atherectomy-systems/hawkone-directional-atherectomy-system.html
Top Companies Market Share in Plaque Modification Devices Industry: (In no particular order of Rank)
| Companies | 2022 (A) | 2023 (A) | 2024 (A) | 2025 (A) |
|---|---|---|---|---|
| Boston Scientific Corporation | xxxx | xxxx | xxxx | xxxx |
| B. Braun Melsungen | xxxx | xxxx | xxxx | xxxx |
| BD (Becton Dickinson and Company) | xxxx | xxxx | xxxx | xxxx |
| Cardinal Health | xxxx | xxxx | xxxx | xxxx |
| Medtronic | xxxx | xxxx | xxxx | xxxx |
| Cardiovascular Systems Inc | xxxx | xxxx | xxxx | xxxx |
| Microvention Inc | xxxx | xxxx | xxxx | xxxx |
| Penumbra Inc | xxxx | xxxx | xxxx | xxxx |
| Biotronic | xxxx | xxxx | xxxx | xxxx |
| Stryker | xxxx | xxxx | xxxx | xxxx |
*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive)
Request Any Company Profile for Preview Purpose OR Data Validation!
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
According to Cognitive Market Research, North America is the dominant market for plaque modification and removal devices. This is largely due to the high incidence of cardiovascular diseases (CVDs) in the region. For instance, the Centers for Disease Control and Prevention (CDC) indicates that more than 795,000 individuals in the United States suffer from a stroke each year, and 87% of them are ischemic strokes. The growing population of older adults also contributes greatly to market growth. Based on the Population Reference Bureau, the population of Americans aged 65 and above is expected to increase from 58 million in 2022 to 82 million in 2050, representing a 47% increase. This population trend highlights an increasing need for sophisticated medical interventions, such as plaque modification devices, to treat age-related cardiovascular diseases. In addition, the region's high rate of adoption of technological innovations and well-developed healthcare infrastructure allow for easy integration of new medical technologies, making plaque removal treatments more accessible and efficient.?
The Asia Pacific region is expected to demonstrate the highest growth in the plaque modification and removal devices market. This high growth is attributed to various factors, such as rising cases of cardiovascular diseases as a result of urbanization and lifestyle changes. The expenditure on healthcare in the region is also increasing, along with infrastructure development, increasing access to new medical treatments. In China, the government's emphasis on enhancing the healthcare infrastructure and increasing access to quality medical services is significantly contributing to the growth in demand for plaque modification and removal devices. Healthcare facility investments, healthcare professional training programs, and preventive care promotion programs are all helping to grow the market by putting in place a favorable environment for the uptake of innovative medical technologies. Likewise, in India too, the increasing incidence of coronary artery disease due to lifestyle modifications, urbanization, and rising prevalence rates of risk factors like hypertension, diabetes, and obesity greatly enhances the demand for such devices. The increasing population also aggravates the occurrence of CVD, which requires more frequent and sophisticated medical interventions. These advancements highlight the region's focus on improving cardiovascular treatment, thus propelling the growth of the plaque modification devices market..
The current report Scope analyzes Plaque Modification Devices Market on 6 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
According to Cognitive Market Research, the global Plaque Modification Devices Market size was estimated at USD 1421.9 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 792.73 million in 2025 and will grow at a compound annual growth rate (CAGR) of 7.6% from 2025 to 2033.
According to Cognitive Market Research, the US had a major share in the Plaque Modification Devices Market with a market size of USD 625.46 million in 2025 and is projected to grow at a CAGR of 7.4% during the forecast period. Technological advancements in atherectomy and thrombectomy devices are enhancing procedural efficacy and patient outcomes.
The Canadian Plaque Modification Devices Market had a market share of USD 95.13 million in 2025 and is projected to grow at a CAGR of 8.4% during the forecast period. The growing adoption of minimally invasive procedures is driving the preference for plaque modification devices.
The Mexico Plaque Modification Devices Market is projected to witness growth at a CAGR of 8.1% during the forecast period, with a market size of USD 72.14 million in 2025..
According to Cognitive Market Research, the global Plaque Modification Devices Market size was estimated at USD 1114.8 Million, out of which Europe held the market share of more than 29% of the global revenue with a market size of USD 621.33 million in 2025 and will grow at a compound annual growth rate (CAGR) of 7.6% from 2025 to 2033.
The United Kingdom Plaque Modification Devices Market had a market share of USD 104.38 million in 2025 and is projected to grow at a CAGR of 8.4% during the forecast period. In the UK, Favorable reimbursement policies in developed countries are making advanced plaque modification procedures more accessible..
The France Plaque Modification Devices Market is projected to witness growth at a CAGR of 6.8% during the forecast period, with a market size of USD 57.16 million in 2025.
According to Cognitive Market Research, the German Plaque Modification Devices Market size was valued at USD 123.02 million in 2025 and is projected to grow at a CAGR of 7.8% during the forecast period. Government initiatives and funding for cardiovascular disease prevention and treatment are boosting market expansion.
The Italy Plaque Modification Devices Market is projected to witness growth at a CAGR of 7.0% during the forecast period, with a market size of USD 53.43 million in 2025.
The Russia Plaque Modification Devices Market is projected to witness growth at a CAGR of 6.6% during the forecast period, with a market size of USD 96.31 million in 2025
The Spain Plaque Modification Devices Market is projected to witness growth at a CAGR of 6.7% during the forecast period with a market size of USD 50.95 million in 2025
The Sweden Plaque Modification Devices Market is projected to witness growth at a CAGR of 7.7% during the forecast period, with a market size of USD 19.26 million in 2025.
The Denmark Plaque Modification Devices Market is projected to witness growth at a CAGR of 7.4% during the forecast period, with a market size of USD 13.05 million in 2025
The Switzerland Plaque Modification Devices Market is projected to witness growth at a CAGR of 7.2% during the forecast period, with a market size of USD 9.32 million in 2025.
The Luxembourg Plaque Modification Devices Market is projected to witness growth at a CAGR of 7.9% during the forecast period, with a market size of USD 7.46 million in 2025.
The Rest of Europe's Plaque Modification Devices Market is projected to witness growth at a CAGR of 6.3% during the forecast period, with a market size of USD 86.99 million in 2025.
According to Cognitive Market Research, the global Plaque Modification Devices Market size was estimated at USD 1241.0 Million, out of which APAC held the market share of around 23% of the global revenue with a market size of USD 514.20 million in 2025 and will grow at a compound annual growth rate (CAGR) of 11.6 from 2025 to 2033.
According to Cognitive Market Research, the China Plaque Modification Devices Market size was valued at USD 215.96 million in 2025 and is projected to grow at a CAGR of 11.1% during the forecast period. Growing awareness about early diagnosis and treatment of cardiovascular diseases is supporting market growth..
The Japan Plaque Modification Devices Market is projected to witness growth at a CAGR of 8.5% during the forecast period, with a market size of USD 1381.38 million in 2025
The South Korea Plaque Modification Devices Market had a market share of USD 70.96 million in 2025 and is projected to grow at a CAGR of 10.1% during the forecast period. Increasing healthcare expenditures and investments in advanced medical technologies are driving market expansion.
The Indian Plaque Modification Devices Market is projected to witness growth at a CAGR of 10.7% during the forecast period, with a market size of USD 61.70 million in 2025.
The Australian Plaque Modification Devices Market is projected to witness growth at a CAGR of 10.3% during the forecast period, with a market size of USD 41.42 million in 2025.
The Singapore Plaque Modification Devices Market is projected to witness growth at a CAGR of 11.9% during the forecast period, with a market size of USD 10.28 million in 2025.
The Taiwan Plaque Modification Devices Market is projected to witness growth at a CAGR of 11.5% during the forecast period, with a market size of USD 20.04 million in 2025.
The South East Asia Plaque Modification Devices Market is projected to witness growth at a CAGR of 12.4% during the forecast period, with a market size of USD 33.94 million in 2025.
The Rest of APAC Plaque Modification Devices Market is projected to witness growth at a CAGR of 11.4% during the forecast period, with a market size of USD 23.14 million in 2025.
According to Cognitive Market Research, the global Plaque Modification Devices Market size was estimated at USD 164.1 Million, out of which South America held the market share of around 5% of the global revenue with a market size of USD 81.42 million in 2025 and will grow at a compound annual growth rate (CAGR) of 9.2% from 2025 to 2033.
According to Cognitive Market Research, the Brazil Plaque Modification Devices Market size was valued at USD 34.85 million in 2025 and is projected to grow at a CAGR of 9.8% during the forecast period. Rapid urbanization and changing lifestyles leading to obesity and hypertension are contributing to higher plaque-related complications.
Argentina's Plaque Modification Devices Market had a market share of USD 13.68 million in 2025 and is projected to grow at a CAGR of 10.1% during the forecast period. The introduction of bioresorbable and drug-coated plaque modification devices is enhancing treatment effectiveness.
Colombia Plaque Modification Devices Market is projected to witness growth at a CAGR of 9.0% during the forecast period, with a market size of USD 7.25 million in 2025
Peru Plaque Modification Devices Market is projected to witness growth at a CAGR of 9.4% during the forecast period, with a market size of USD 6.68 million in 2025.
Chile Plaque Modification Devices Market is projected to witness growth at a CAGR of 9.5% during the forecast period, with a market size of USD 5.86 million in 2025
The Rest of South America's Plaque Modification Devices Market is projected to witness growth at a CAGR of 8.3% during the forecast period, with a market size of USD 13.11 million in 2025.
According to Cognitive Market Research, the global Plaque Modification Devices Market size was estimated at USD 174.6 Million, out of which the Middle East held the major market share of around 2% of the global revenue with a market size of USD 85.70 million in 2025 and will grow at a compound annual growth rate (CAGR) of 9.3% from 2025 to 2033..
The Qatar Plaque Modification Devices Market is projected to witness growth at a CAGR of 8.8% during the forecast period, with a market size of USD 6.86 million in 2025. Increasing demand for outpatient and ambulatory care settings is boosting the adoption of portable plaque modification devices.
The Saudi Arabia Plaque Modification Devices Market is projected to witness growth at a CAGR of 9.6% during the forecast period, with a market size of USD 30.17 million in 2025.
The Turkey Plaque Modification Devices Market is projected to witness growth at a CAGR of 9.9% during the forecast period, with a market size of USD 6.86 million in 2025. Collaborations between medical device manufacturers and healthcare institutions are fostering innovation and market penetration.
The UAE Plaque Modification Devices Market is projected to witness growth at a CAGR of 9.8% during the forecast period, with a market size of USD 17.65 million in 2025.
The Egypt Plaque Modification Devices Market is projected to witness growth at a CAGR of 9.1% during the forecast period, with a market size of USD 5.14 million in 2025.
The Rest of the Middle East Plaque Modification Devices Market is projected to witness growth at a CAGR of 8.5% during the forecast period, with a market size of USD 19.03 million in 2025
According to Cognitive Market Research, the global Plaque Modification Devices Market size was estimated at USD 90.4 Million, out of which Africa held the major market share of around 2% of the global revenue with a market size of USD 47.14million in 2025 and will grow at a compound annual growth rate (CAGR) of 8.5% from 2025 to 2033..
The Nigeria Plaque Modification Devices Market is projected to witness growth at a CAGR of 8.7% during the forecast period, with a market size of USD 3.77 million in 2025Rising healthcare infrastructure development in emerging economies is expanding market opportunities.
The South Africa Plaque Modification Devices Market is projected to witness growth at a CAGR of 9.4% during the forecast period, with a market size of USD 16.59 million in 2025.
The Rest of Africa Plaque Modification Devices Market is projected to witness growth at a CAGR of 7.7% during the forecast period, with a market size of USD 26.77 million in 2025.
Conclusion
Research Analyst at Cognitive Market Research
LinkedIn | Profile | Book Appointment
Supriya Yadav is a skilled market researcher with strong expertise in the Medical Devices and Consumables industry. Known for her analytical precision and deep interest in healthcare innovation, she focuses on decoding key market trends, technological advancements, and evolving customer needs. Supriya excels at transforming complex industry data into meaningful insights that support strategic decision-making for healthcare stakeholders. Her commitment to understanding the future of medical technologies and improving patient-centric solutions makes her a valuable contributor in this rapidly advancing sector.
As a Research Analyst, I bring over two years of experience in market research, data analysis, and market estimation. I specialize in turning complex datasets into meaningful insights that help businesses identify opportunities, understand market dynamics, and make confident, growth-focused decisions.
My expertise spans across analyzing industry trends, forecasting market potential, mapping competitive landscapes, and studying consumer behavior to deliver actionable recommendations. With an MBA in Marketing and Finance, I combine strong analytical skills with strategic thinking, ensuring that every project I work on contributes real value to clients.
I am passionate about using research to uncover patterns, anticipate shifts, and deliver insights that drive measurable business impact. My goal is to continuously learn, innovate, and provide data-driven solutions that empower clients to succeed in a competitive environment.
Global Plaque Modification Devices Market Report 2025 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Plaque Modification Devices Industry growth. Plaque Modification Devices market has been segmented with the help of its Product Type Outlook:, Application Outlook: End-user Outlook:, and others. Plaque Modification Devices market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
How are Segments Performing in the Global Plaque Modification Devices Market?
According to Cognitive Market Research, Atherectomy devices have become the dominant segment in the plaque modification and removal devices market. The devices are used to eliminate atherosclerotic plaque from arteries, overcoming the limitations posed by conventional balloon angioplasty, including vessel recoil and stenosis residuum. The success of atherectomy devices in eliminating complex lesions, such as severely calcified plaques, has helped them find common ground with most healthcare experts. Moreover, technological improvements have made the devices safer and more effective, solidifying their stranglehold in the market further.
Embolic Protection Devices (EPDs) are witnessing high growth in the plaque modification and removal devices market. EPDs play a vital role in capturing and extracting debris that can dislodge during interventional procedures, thus minimizing the risk of distal embolization and related complications. The rising use of minimally invasive surgeries, along with an increased focus on patient safety and procedural success, has driven the demand for EPDs. With healthcare professionals committing more and more to measures that reduce procedural risks, the EPD segment is likely to continue its growth path and become the fastest-growing segment in the market.
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Plaque Modification Devices Industry. Request a Free Sample PDF!
According to Cognitive Market Research, the Coronary Artery Disease (CAD) segment is the leading application in the plaque modification and removal devices market. The reason for this dominance is mainly due to the widespread prevalence of CAD worldwide, fueled by risk factors like hypertension, diabetes, obesity, and physical inactivity. The growing prevalence of atherosclerosis requires efficient treatment methods, hence increasing the demand for plaque modification devices. The advancements in technology, such as atherectomy and thrombectomy devices, have improved procedural success rates, further establishing the supremacy of the CAD segment. Moreover, the rising elderly population, which is prone to cardiovascular diseases, is adding to the continuous demand for these devices. Healthcare systems globally are focusing on early diagnosis and treatment of CAD, which is contributing to the higher uptake of plaque modification technologies.
In the Plaque Modification Devices Market, the Peripheral Artery Disease (PAD) segment is expected to grow the fastest in the plaque modification and removal devices market over the forecast period. The acceleration of this growth comes from the increasing incidence of PAD, especially among the elderly and diabetic patients. Life habits like smoking and physical inactivity also lead to an increased incidence of PAD. Increased knowledge about PAD and its complications has resulted in earlier detection and treatment, creating increased demand for efficient plaque removal devices. Minimally invasive procedures are preferred due to their shorter recovery periods and fewer complications, and they are increasingly being used in the treatment of PAD, further stimulating market growth. In addition, healthcare programs aimed at vascular health and the development of healthcare infrastructure in emerging markets are anticipated to drive the strong growth of the PAD segment.
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
According to Cognitive Market Research, Hospitals are the leading end-user segment in the market for plaque modification and removal devices. This is mainly due to the extensive infrastructure and ability of hospitals to treat complex cardiovascular procedures. Hospitals usually possess state-of-the-art medical technologies and are manned by professional healthcare experts, allowing them to conduct complex interventions like atherectomy and thrombectomy procedures. Also, the capacity of hospitals to treat emergency cases and deliver intensive postoperative care makes them the setting of choice for patients in need of plaque modification procedures. Incorporating multidisciplinary teams into hospitals allows for integrated patient management, leading to enhanced clinical outcomes and solidifying their market-leading position.
In the Plaque Modification Devices Market, Ambulatory Surgical Centers (ASCs) are expected to emerge as the quickest-growing end-user segment in the plaque modification and removal devices market. This growth is fueled by the growing transition towards outpatient treatments and minimally invasive procedures. ASCs present a number of benefits, including shorter hospital stays, cost-saving, and the reduced risk of hospital-acquired infections. The efficiency and convenience that come with ASCs make them a favorable choice for both healthcare providers and patients. With increasing technology, the safety and viability of carrying out intricate procedures on an outpatient basis will only improve further, leading to increased usage of plaque modification devices in ASCs at a large rate, thus making their market growth tremendous.
Disclaimer:
| Product Type Outlook: | Atherectomy Devices, Thrombectomy Devices, Chronic Total Occlusion (CTO) Devices, Embolic Protection Devices (EPD) |
| Application Outlook: | Coronary Artery Disease, Peripheral Artery Disease, Neurovascular Disease, Others |
| End-user Outlook: | Hospitals, Specialty Clinics, Ambulatory Surgical Centers |
| List of Competitors | Boston Scientific Corporation, B. Braun Melsungen, BD (Becton Dickinson and Company), Cardinal Health, Medtronic, Cardiovascular Systems Inc, Microvention Inc, Penumbra Inc, Biotronic, Stryker |
Chapter 1 2026 Geopolitical Outlook - Plaque Modification Devices Market Detailed Analysis
This chapter isn't just about technology; it’s about certainty. We show you how AI is being used in leading industries so you can apply those same 'High-Speed' and 'High-Accuracy' principles to your own market strategy
Chapter 2 AI's Impact on Market - Detailed Qualitative Analysis
This chapter will help you gain GLOBAL Market Analysis of Plaque Modification Devices. Further deep in this chapter, you will be able to review Global Plaque Modification Devices Market Split by various segments and Geographical Split.
Chapter 3 Global Market Analysis
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
This chapter will help you gain North America Market Analysis of Plaque Modification Devices. Further deep in this chapter, you will be able to review North America Plaque Modification Devices Market Split by various segments and Country Split.
Chapter 4 North America Market Analysis
This chapter will help you gain Europe Market Analysis of Plaque Modification Devices. Further deep in this chapter, you will be able to review Europe Plaque Modification Devices Market Split by various segments and Country Split.
Chapter 5 Europe Market Analysis
This chapter will help you gain Asia Pacific Market Analysis of Plaque Modification Devices. Further deep in this chapter, you will be able to review Asia Pacific Plaque Modification Devices Market Split by various segments and Country Split.
Chapter 6 Asia Pacific Market Analysis
This chapter will help you gain South America Market Analysis of Plaque Modification Devices. Further deep in this chapter, you will be able to review South America Plaque Modification Devices Market Split by various segments and Country Split.
Chapter 7 South America Market Analysis
This chapter will help you gain Middle East Market Analysis of Plaque Modification Devices. Further deep in this chapter, you will be able to review Middle East Plaque Modification Devices Market Split by various segments and Country Split.
Chapter 8 Middle East Market Analysis
This chapter will help you gain Middle East Market Analysis of Plaque Modification Devices. Further deep in this chapter, you will be able to review Middle East Plaque Modification Devices Market Split by various segments and Country Split.
Chapter 9 Africa Market Analysis
This chapter provides an in-depth analysis of the market share among key competitors of Plaque Modification Devices. The analysis highlights each competitor's position in the market, growth trends, and financial performance, offering insights into competitive dynamics, and emerging players.
Chapter 10 Competitor Analysis (Subject to Data Availability (Private Players))
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
This chapter would comprehensively cover market drivers, trends, restraints, opportunities, and various in-depth analyses like industrial chain, PESTEL, Porter’s Five Forces, and ESG, among others. It would also include product life cycle, technological advancements, and patent insights.
Chapter 11 Qualitative Analysis (Subject to Data Availability)
Segmentation Product Type Outlook: Analysis 2019 -2031, will provide market size split by Product Type Outlook:. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 12 Market Split by Product Type Outlook: Analysis 2022 - 2034
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 13 Market Split by Application Outlook: Analysis 2022 - 2034
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 14 Market Split by End-user Outlook: Analysis 2022 - 2034
Chapter 15 Plaque Modification Devices Price Trend Analysis
Chapter 16 Plaque Modification Devices Import/Export Analysis
Chapter 17 Plaque Modification Devices Production Analysis
Chapter 18 Gap Analysis
Chapter 19 Strategy Analysis
Chapter 20 Profitability and Gross Margin Analysis
Chapter 21 TAM Analysis
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Plaque Modification Devices market
Chapter 22 Research Findings
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Chapter 23 Research Methodology and Sources
1 Data Gathering
2 Data Validation
3 Data Presentation
To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for our full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants your team direct access to our lead analysts for bespoke strategic consultation.